eHealth Stock Price Target and Analyst Ratings (NASDAQ:EHTH)

Analyst Price Target for EHTH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$110.77

▲ +57.90% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for eHealth in the last 3 months. The average price target is $110.77, with a high forecast of $200.00 and a low forecast of $63.00. The average price target represents a 57.90% upside from the last price of $70.15.

Buy

The current consensus among 12 polled investment analysts is to buy stock in eHealth. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

1 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

10/25/2019

1 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/23/2020

1 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

4/22/2020

1 strong buy ratings
8 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

7/21/2020

0 strong buy ratings
8 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

10/19/2020

0 strong buy ratings
8 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/17/2021

0 strong buy ratings
8 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

3/18/2021

0 strong buy ratings
8 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/17/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
3/31/2021	The Goldman Sachs Group	Reiterated Rating	Buy ➝ Neutral	$63.00	Low	i
3/30/2021	Craig Hallum	Boost Price Target	Buy	$65.00 ➝ $85.00	Low	i
3/29/2021	Evercore ISI	Boost Price Target	Outperform	$60.00 ➝ $80.00	N/A	i
3/25/2021	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$63.00	High	i
3/23/2021	Credit Suisse Group	Boost Price Target	Outperform	$63.00 ➝ $78.00	High	i
3/23/2021	Evercore ISI	Boost Price Target	Positive ➝ Outperform	$60.00 ➝ $80.00	High	i
2/25/2021	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy ➝ Hold	$63.00	Medium	i
2/24/2021	Raymond James	Reiterated Rating	Hold		Medium	i
2/19/2021	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$124.00 ➝ $63.00	High	i
2/2/2021	The Goldman Sachs Group	Lower Price Target	Buy	$101.00 ➝ $64.00	Low	i
2/1/2021	Truist	Lower Price Target		$200.00 ➝ $100.00	Low	i
2/1/2021	Craig Hallum	Lower Price Target	Buy	$150.00 ➝ $65.00	Low	i
2/1/2021	Raymond James	Downgrade	Outperform ➝ Market Perform		Low	i
2/1/2021	Barclays	Lower Price Target	Overweight	$115.00 ➝ $75.00	Low	i
1/29/2021	Royal Bank of Canada	Downgrade	Outperform ➝ Sector Perform		High	i
12/14/2020	SVB Leerink	Lower Price Target	Outperform	$110.00 ➝ $105.00	Low	i
10/23/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$138.00 ➝ $124.00	High	i
10/2/2020	Raymond James	Reiterated Rating	Buy		High	i
9/25/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$101.00	High	i
9/8/2020	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$110.00	High	i
8/6/2020	Credit Suisse Group	Reiterated Rating	Buy	$130.00	Low	i Rating by Jailendra Singh at Credit Suisse Group AG
7/27/2020	Raymond James	Lower Price Target	Outperform	$165.00 ➝ $115.00	High	i
7/24/2020	SunTrust Banks	Lower Price Target		$250.00 ➝ $200.00	Low	i Rating by Tobey Sommer at SunTrust Banks, Inc.
7/24/2020	Craig Hallum	Lower Price Target	Buy	$200.00 ➝ $150.00	High	i
7/24/2020	Credit Suisse Group	Lower Price Target	Outperform	$174.00 ➝ $156.00	High	i Rating by Jailendra Singh at Credit Suisse Group AG
7/24/2020	SVB Leerink	Boost Price Target	Market Perform	$108.00 ➝ $110.00	High	i
7/24/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$138.00 ➝ $170.00	High	i
7/24/2020	Royal Bank of Canada	Boost Price Target	Outperform	$127.00 ➝ $166.00	High	i
7/24/2020	Citigroup	Lower Price Target	Buy	$135.00 ➝ $125.00	High	i Rating by Daniel Grosslight at Citigroup Inc.
7/24/2020	Barclays	Lower Price Target	Market Perform ➝ Overweight	$150.00 ➝ $140.00	High	i
7/14/2020	Citigroup	Initiated Coverage	Buy	$135.00	High	i
7/1/2020	SVB Leerink	Initiated Coverage	Market Perform	$108.00	High	i
6/15/2020	Evercore ISI	Initiated Coverage	Buy	$150.00	Low	i Rating by Michael Newshel at Evercore ISI
4/29/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$185.00	Low	i Rating by Steven Halper at Cantor Fitzgerald
4/27/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$177.00 ➝ $170.00	High	i
4/24/2020	SunTrust Banks	Reiterated Rating	Buy	$250.00	High	i Rating by Tobey Sommer at SunTrust Banks, Inc.
4/24/2020	Credit Suisse Group	Initiated Coverage	Buy	$174.00	High	i Rating by Jailendra Singh at Credit Suisse Group AG
4/16/2020	Barclays	Initiated Coverage	Overweight	$150.00	Low	i
2/24/2020	SunTrust Banks	Boost Price Target	Buy	$200.00 ➝ $250.00	High	i Rating by Tobey Sommer at SunTrust Banks, Inc.
2/24/2020	Credit Suisse Group	Boost Price Target	Buy ➝ Outperform	$145.00 ➝ $179.00	High	i
2/21/2020	Craig Hallum	Boost Price Target	Buy	$150.00 ➝ $200.00	High	i
2/21/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$163.00 ➝ $177.00	High	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
2/21/2020	Royal Bank of Canada	Boost Price Target	Outperform	$132.00 ➝ $166.00	High	i Rating by Frank Morgan at Royal Bank of Canada
2/21/2020	Cantor Fitzgerald	Reiterated Rating	Overweight	$150.00 ➝ $185.00	High	i Rating by Steven Halper at Cantor Fitzgerald
2/18/2020	SunTrust Banks	Reiterated Rating	Buy	$200.00	Medium	i Rating by Tobey Sommer at SunTrust Banks, Inc.
1/28/2020	Raymond James	Boost Price Target	Outperform	$90.00 ➝ $135.00	Medium	i Rating by Charles Peters at Raymond James
1/24/2020	Craig Hallum	Boost Price Target	Buy	$110.00 ➝ $150.00	High	i
1/24/2020	Credit Suisse Group	Boost Price Target	Outperform	$134.00 ➝ $145.00	High	i
1/24/2020	Royal Bank of Canada	Boost Price Target	Outperform	$111.00 ➝ $132.00	High	i Rating by Frank Morgan at Royal Bank of Canada
1/24/2020	Cantor Fitzgerald	Reiterated Rating	Overweight	$120.00 ➝ $150.00	High	i Rating by Steven Halper at Cantor Fitzgerald
1/17/2020	SunTrust Banks	Reiterated Rating	Buy	$200.00	High	i Rating by Tobey Sommer at SunTrust Banks, Inc.
10/25/2019	Cantor Fitzgerald	Set Price Target	Buy	$120.00	Low	i Rating by Steven Halper at Cantor Fitzgerald
10/25/2019	Royal Bank of Canada	Set Price Target	Buy	$111.00	Low	i Rating by Frank Morgan at Royal Bank of Canada
10/25/2019	Raymond James	Set Price Target	Buy	$90.00	Low	i Rating by Charles Peters at Raymond James
10/14/2019	Raymond James	Initiated Coverage	Outperform	$90.00	High	i
9/27/2019	Evercore ISI	Set Price Target	Buy	$125.00	High	i Rating by Michael Newshel at Evercore ISI
9/27/2019	Credit Suisse Group	Upgrade	Outperform		Medium	i
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$173.00	Low	i
9/6/2019	SunTrust Banks	Set Price Target	Buy	$150.00	High	i Rating by Tobey Sommer at SunTrust Banks, Inc.
8/6/2019	Credit Suisse Group	Boost Price Target	Outperform	$118.00 ➝ $136.00	Medium	i
7/29/2019	First Analysis	Upgrade	Outperform ➝ Strong-Buy	$106.00 ➝ $136.00	Medium	i Rating by Frank Sparacino at First Analysis
7/26/2019	Royal Bank of Canada	Boost Price Target	Outperform ➝ Outperform	$89.00 ➝ $111.00	High	i Rating by George Hill at Royal Bank of Canada
7/26/2019	SunTrust Banks	Boost Price Target	Buy ➝ Positive	$150.00	High	i
7/26/2019	Cantor Fitzgerald	Boost Price Target	Overweight	$100.00 ➝ $120.00	High	i
7/19/2019	First Analysis	Initiated Coverage	Outperform ➝ Outperform	$106.00	Low	i
7/10/2019	Credit Suisse Group	Initiated Coverage	Outperform	$104.00	Medium	i
5/15/2019	SunTrust Banks	Boost Price Target	Buy	$120.00	High	i
5/8/2019	Cantor Fitzgerald	Boost Price Target	Overweight	$87.00 ➝ $100.00	Low	i
4/29/2019	Cantor Fitzgerald	Reiterated Rating	Overweight	$73.00 ➝ $87.00	Low	i
4/26/2019	Royal Bank of Canada	Set Price Target	Buy	$89.00	Medium	i Rating by George Hill at Royal Bank of Canada
4/26/2019	Craig Hallum	Reiterated Rating	Buy	$75.00 ➝ $85.00	High	i
4/10/2019	SunTrust Banks	Boost Price Target	Buy	$90.00	Medium	i
2/22/2019	SunTrust Banks	Boost Price Target	Positive ➝ Buy	$75.00	High	i
2/20/2019	Royal Bank of Canada	Boost Price Target	Outperform ➝ Outperform	$57.00 ➝ $83.00	Medium	i
2/4/2019	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$75.00	Medium	i
1/28/2019	Craig Hallum	Boost Price Target	Buy	$37.00 ➝ $75.00	Low	i
1/24/2019	Chardan Capital	Reiterated Rating	Buy ➝ Buy	$40.00 ➝ $65.00	High	i
1/23/2019	SunTrust Banks	Boost Price Target	Positive ➝ Buy	$60.00	High	i
1/23/2019	Cantor Fitzgerald	Reiterated Rating	Overweight	$56.00	High	i
12/20/2018	SunTrust Banks	Boost Price Target	Buy	$50.00	High	i
12/20/2018	Royal Bank of Canada	Initiated Coverage	Outperform ➝ Outperform	$57.00	High	i
10/25/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$39.00	High	i
10/8/2018	Cantor Fitzgerald	Boost Price Target	Overweight	$39.00	Low	i
8/16/2018	Chardan Capital	Initiated Coverage	Buy	$40.00	High	i
7/27/2018	Cantor Fitzgerald	Reiterated Rating	Overweight	$26.00	High	i
5/18/2018	Cantor Fitzgerald	Boost Price Target	Overweight	$22.00	High	i
3/6/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$20.00	High	i
12/11/2017	Craig Hallum	Reiterated Rating	Buy	$28.00	Low	i
10/30/2017	Jefferies Financial Group	Boost Price Target	Hold	$20.00 ➝ $23.00	N/A	i
10/27/2017	SunTrust Banks	Reiterated Rating	Buy	$30.00	N/A	i
10/20/2017	SunTrust Banks	Reiterated Rating	Buy	$22.00	N/A	i
10/19/2017	Wells Fargo & Company	Boost Price Target	Market Perform	$18.00 ➝ $24.00	N/A	i
10/18/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$27.00	N/A	i
10/2/2017	Cantor Fitzgerald	Boost Price Target	Overweight	$21.00 ➝ $27.00	High	i
8/26/2017	Jefferies Financial Group	Reiterated Rating	Hold	$18.00 ➝ $20.00	High	i
8/20/2017	Jefferies Financial Group	Boost Price Target	Hold	$18.00 ➝ $20.00	Low	i
7/27/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$20.00	Low	i
7/14/2017	Jefferies Financial Group	Reiterated Rating	Hold	$18.00	Low	i
5/11/2017	Jefferies Financial Group	Boost Price Target	Hold	$15.00 ➝ $20.00	Low	i
5/11/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$20.00	Medium	i
3/30/2017	Jefferies Financial Group	Reiterated Rating	Hold	$11.50	Low	i
3/23/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$15.00	Low	i
3/17/2017	Cantor Fitzgerald	Reiterated Rating	Overweight	$15.00	High	i
2/27/2017	Cantor Fitzgerald	Reiterated Rating	Overweight	$15.00	N/A	i
2/24/2017	Jefferies Financial Group	Boost Price Target	Hold	$9.50 ➝ $11.50	N/A	i
1/11/2017	Craig Hallum	Upgrade	Hold ➝ Buy	$15.00	N/A	i
1/5/2017	Cantor Fitzgerald	Initiated Coverage	Overweight	$15.00	N/A	i
10/28/2016	Craig Hallum	Downgrade	Buy ➝ Hold	$13.00 ➝ $11.00	N/A	i Rating by George Sutton at Craig Hallum
8/23/2016	(FBRC)	Reiterated Rating	Buy		N/A	i Rating by Steven Halper at (FBRC)
8/5/2016	Craig Hallum	Upgrade	Hold ➝ Buy		N/A	i Rating by George Sutton at Craig Hallum
7/29/2016	(FBRC)	Reiterated Rating	Buy	$17.00	N/A	i Rating by Steven Halper at (FBRC)
7/29/2016	Jefferies Financial Group	Lower Price Target	Hold	$13.00 ➝ $12.00	N/A	i Rating by David Styblo at Jefferies Financial Group Inc.
7/29/2016	Craig Hallum	Downgrade	Buy ➝ Hold		N/A	i Rating by George Sutton at Craig Hallum
7/12/2016	(FBRC)	Reiterated Rating	Outperform	$17.00	N/A	i Rating by Steven Halper at (FBRC)
6/12/2016	Jefferies Financial Group	Reiterated Rating	Hold		N/A	i Rating by David Styblo at Jefferies Financial Group Inc.
6/10/2016	(FBRC)	Reiterated Rating	Buy		N/A	i
4/29/2016	Craig Hallum	Upgrade	Hold ➝ Buy	$15.00	N/A	i Rating by G. Sutton at Craig Hallum

(Data available from 4/17/2016 forward)

eHealth, Inc. provides private health insurance exchange services to individuals, families, and small businesses in the United States and China. The company operates through two segments, Medicare; and Individual, Family and Small Business. Its ecommerce platforms organize and present health insurance information in various formats that enable individuals, families, and small businesses to research, analyze, compare, and purchase a range of health insurance plans. The company's Medicare-related health insurance plans include medicare advantage, medicare supplement, and medicare part D prescription drug plans; and ancillary products, including dental, vision, and short and long term disability insurance plans. It markets health insurance plans through its websites, such as eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com, as well as through a network of marketing partners. The company also licenses its health insurance ecommerce technology that enables health insurance carriers, agents, and brokers to market and distribute health insurance plans online; and provides online sponsorship and advertising services. eHealth, Inc. was founded in 1997 and is headquartered in Santa Clara, California.

Today's Range

Now: $70.15

$68.67

$70.45

50 Day Range

MA: $65.45

$51.03

$74.13

52 Week Range

Now: $70.15

$47.84

$137.49

Volume

210,746 shs

Average Volume

1,245,225 shs

Market Capitalization

$1.82 billion

P/E Ratio

23.15

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of eHealth?

The following sell-side analysts have issued research reports on eHealth in the last twelve months: Barclays PLC, Cantor Fitzgerald, Citigroup Inc., Craig Hallum, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Raymond James, Royal Bank of Canada, SunTrust Banks, Inc., SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, and Zacks Investment Research.
View the latest analyst ratings for EHTH.

What is the current price target for eHealth?

13 Wall Street analysts have set twelve-month price targets for eHealth in the last year. Their average twelve-month price target is $110.77, suggesting a possible upside of 57.9%. SunTrust Banks, Inc. has the highest price target set, predicting EHTH will reach $200.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $63.00 for eHealth in the next year.
View the latest price targets for EHTH.

What is the current consensus analyst rating for eHealth?

eHealth currently has 4 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EHTH will outperform the market and that investors should add to their positions of eHealth.
View the latest ratings for EHTH.

What other companies compete with eHealth?

Other companies that are similar to eHealth include SelectQuote, Ashmore Group, Goosehead Insurance, GoHealth, BRP Group, CorVel, Fanhua, Huize, AA, The Marketing Alliance, Arista Investors, Patriot National and UMC.

How do I contact eHealth's investor relations team?

eHealth's physical mailing address is 2625 AUGUSTINE DRIVE SECOND FLOOR, SANTA CLARA CA, 95054. The financial services provider's listed phone number is 650-584-2700 and its investor relations email address is [email protected] The official website for eHealth is www.ehealthinsurance.com.

NASDAQ:EHTH - eHealth Stock Price Target and Predictions

Analyst Price Target for EHTH

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of eHealth?

What is the current price target for eHealth?

What is the current consensus analyst rating for eHealth?

What other companies compete with eHealth?

How do I contact eHealth's investor relations team?